BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 30246494)

  • 21. Reduced von Willebrand factor survival in type Vicenza von Willebrand disease.
    Casonato A; Pontara E; Sartorello F; Cattini MG; Sartori MT; Padrini R; Girolami A
    Blood; 2002 Jan; 99(1):180-4. PubMed ID: 11756169
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison between von Willebrand factor (VWF) and VWF antigen II in normal individuals and patients with von Willebrand disease.
    de Romeuf C; Mazurier C
    Thromb Haemost; 1998 Jul; 80(1):37-41. PubMed ID: 9684782
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Type 2M:Milwaukee-1 von Willebrand disease: an in-frame deletion in the Cys509-Cys695 loop of the von Willebrand factor A1 domain causes deficient binding of von Willebrand factor to platelets.
    Mancuso DJ; Kroner PA; Christopherson PA; Vokac EA; Gill JC; Montgomery RR
    Blood; 1996 Oct; 88(7):2559-68. PubMed ID: 8839848
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Abnormal von Willebrand factor secretion, factor VIII stabilization and thrombus dynamics in type 2N von Willebrand disease mice.
    Swystun LL; Georgescu I; Mewburn J; Deforest M; Nesbitt K; Hebert K; Dwyer C; Brown C; Notley C; Lillicrap D
    J Thromb Haemost; 2017 Aug; 15(8):1607-1619. PubMed ID: 28581694
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Successful Perioperative Management of Orthotopic Cardiac Transplantation in a Pediatric Patient With Concurrent Congenital von Willebrand Disease and Acquired von Willebrand Syndrome Using Recombinant von Willebrand Factor.
    Batsuli G; Zimowski KL; Carroll R; White MH; Woods GM; Meeks SL; Sidonio RF
    J Cardiothorac Vasc Anesth; 2022 Mar; 36(3):724-727. PubMed ID: 33618961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular genetics of von Willebrand disease.
    Mazurier C; Ribba AS; Gaucher C; Meyer D
    Ann Genet; 1998; 41(1):34-43. PubMed ID: 9599650
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Getting at the variable expressivity of von Willebrand disease.
    Levy G; Ginsburg D
    Thromb Haemost; 2001 Jul; 86(1):144-8. PubMed ID: 11487001
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Restoration of plasma von Willebrand factor deficiency is sufficient to correct thrombus formation after gene therapy for severe von Willebrand disease.
    De Meyer SF; Vandeputte N; Pareyn I; Petrus I; Lenting PJ; Chuah MK; VandenDriessche T; Deckmyn H; Vanhoorelbeke K
    Arterioscler Thromb Vasc Biol; 2008 Sep; 28(9):1621-6. PubMed ID: 18556568
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic analysis of 31 Swedish type 1 von Willebrand disease families reveals incomplete linkage to the von Willebrand factor gene and a high frequency of a certain disease haplotype.
    Lanke E; Johansson AM; Halldén C; Lethagen S
    J Thromb Haemost; 2005 Dec; 3(12):2656-63. PubMed ID: 16359504
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genome-wide association studies identify genetic loci for low von Willebrand factor levels.
    van Loon J; Dehghan A; Weihong T; Trompet S; McArdle WL; Asselbergs FW; Chen MH; Lopez LM; Huffman JE; Leebeek FW; Basu S; Stott DJ; Rumley A; Gansevoort RT; Davies G; Wilson JJ; Witteman JC; Cao X; de Craen AJ; Bakker SJ; Psaty BM; Starr JM; Hofman A; Wouter Jukema J; Deary IJ; Hayward C; van der Harst P; Lowe GD; Folsom AR; Strachan DP; Smith N; de Maat MP; O'Donnell C
    Eur J Hum Genet; 2016 Jul; 24(7):1035-40. PubMed ID: 26486471
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Homozygous type 2N R854W von Willebrand factor is poorly secreted and causes a severe von Willebrand disease phenotype.
    Castaman G; Giacomelli SH; Jacobi P; Obser T; Budde U; Rodeghiero F; Haberichter SL; Schneppenheim R
    J Thromb Haemost; 2010 Sep; 8(9):2011-6. PubMed ID: 20586924
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic linkage of two intragenic restriction fragment length polymorphisms with von Willebrand's disease type IIA. Evidence for a defect in the von Willebrand factor gene.
    Verweij CL; Quadt R; Briët E; Dubbeldam K; van Ommen GB; Pannekoek H
    J Clin Invest; 1988 Apr; 81(4):1116-21. PubMed ID: 2895123
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factor VIII and von Willebrand factor changes after desmopressin and during pregnancy in type 2M von Willebrand disease Vicenza: a prospective study comparing patients with single (R1205H) and double (R1205H-M740I) defect.
    Castaman G; Federici AB; Bernardi M; Moroni B; Bertoncello K; Rodeghiero F
    J Thromb Haemost; 2006 Feb; 4(2):357-60. PubMed ID: 16420565
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduced von Willebrand factor survival in von Willebrand disease: pathophysiologic and clinical relevance.
    Castaman G; Tosetto A; Rodeghiero F
    J Thromb Haemost; 2009 Jul; 7 Suppl 1():71-4. PubMed ID: 19630772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cosegregation of von Willebrand factor gene polymorphisms and possible germinal mosaicism in type IIB von Willebrand disease.
    Murray EW; Giles AR; Bridge PJ; Peake IR; Lillicrap DP
    Blood; 1991 Apr; 77(7):1476-83. PubMed ID: 2009368
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Laboratory aspects of von Willebrand disease: test repertoire and options for activity assays and genetic analysis.
    Castaman G; Hillarp A; Goodeve A
    Haemophilia; 2014 May; 20 Suppl 4(0 4):65-70. PubMed ID: 24762278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Laboratory diagnosis and molecular classification of von Willebrand disease.
    Gadisseur A; Hermans C; Berneman Z; Schroyens W; Deckmyn H; Michiels JJ
    Acta Haematol; 2009; 121(2-3):71-84. PubMed ID: 19506352
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Variable content of von Willebrand factor mutant monomer drives the phenotypic variability in a family with von Willebrand disease.
    Chen J; Hinckley JD; Haberichter S; Jacobi P; Montgomery R; Flood VH; Wong R; Interlandi G; Chung DW; López JA; Di Paola J
    Blood; 2015 Jul; 126(2):262-9. PubMed ID: 26019279
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dispatch and delivery at the ER-Golgi interface: how endothelial cells tune their hemostatic response.
    Kat M; Margadant C; Voorberg J; Bierings R
    FEBS J; 2022 Nov; 289(22):6863-6870. PubMed ID: 35246944
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [von Willebrand factor and von Willebrand disease].
    Matsui T; Hamako J
    Rinsho Ketsueki; 2016; 57(10):2113-2123. PubMed ID: 27795521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.